Sec. 2. Opioid overdose reversal drug standard
508 words·~2 min read·
/bill/118/hr/6243/ih/section-2A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
Not later than 1 year after the date of enactment of this Act, the Secretary of Labor shall issue an interim final standard on workplace availability of an opioid overdose reversal drug or device— to require all employers to possess an opioid overdose reversal drug or device on site, where the required number of doses of such drug or device required is determined on the basis of the number of employees of the employer on site, type of occupation, and an assessment of potential use; that establishes guidelines for training on— identifying signs and symptoms indicating that usage of an opioid overdose drug or device is necessary; and how to administer such opioid overdose reversal drug or device; and that provides for a period as determined appropriate by the Secretary, not to exceed 1 year, during which the Secretary shall prioritize technical assistance and advice consistent with section 21(d) of the Occupational Safety and Health Act of 1970 ( 29 U.S.C. 670(d) ) to employers subject to the standard with respect to compliance with the standard.
The interim final standard shall— take effect on a date that is not later than 30 days after issuance; shall have the same legal effect as an occupational safety and health standard as defined by section 3 of the Occupational Safety and Health Act of 1970 ( 29 U.S.C. 652 ); and be in effect until the final standard described in subsection
(b)becomes effective and enforceable. If an interim final standard described in paragraph
(1)is not issued by the date that is 1 year after the date of enactment of this Act, the provisions of this Act shall be in effect and enforced in the same manner and to the same extent as any standard promulgated under section 6(b) of the Occupational Safety and Health Act ( 29 U.S.C. 655(b) ) until such provisions are superseded in whole by an interim final standard issued by the Secretary that meets the requirements of paragraph (1). Not later than 2 years after the date of enactment of this Act, the Secretary of Labor shall, pursuant to section 6 of the Occupational Safety and Health Act ( 29 U.S.C. 655 ), promulgate a final standard on workplace availability of opioid overdose reversal drugs or devices— for the purposes described in subsection (a)(1)(A); that shall include, at a minimum, requirements contained in the interim final standard promulgated under subsection (a); and be effective and enforceable in the same manner and to the same extent as any standard promulgated under section 6(b) of the Occupational Safety and Health Act of 1970 ( 29 U.S.C. 655(b) ). In this section: The terms employee and employer have the meaning given such terms in section 3 of the Occupational Safety and Health Act of 1970 ( 29 U.S.C. 652 ). The term opioid overdose reversal drug or device means an opioid overdose reversal drug or device approved, licensed, cleared, or otherwise authorized for marketing by the Food and Drug Administration. The term Secretary means the Secretary of Labor.
Connectionstraces to 3
Traces to 3 documents
Citation graph
cites case law
Cites 3Cited by 0 across 0 sources